This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Pfizer Corporation. Active years: 1993-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Groton, CT (US) (1993 - 1994)
- Ledyard, CT (US) (2022)
Company Filing History:
Years Active: 1993-2022
Title: Paul Bowles: Innovator in Pharmaceutical Chemistry
Introduction
Paul Bowles is a notable inventor based in Groton, Connecticut, who has made significant contributions to the field of pharmaceutical chemistry. With a total of three patents to his name, Bowles has focused on developing innovative solutions for treating abnormal cell growth, including cancer.
Latest Patents
One of Bowles' latest patents is for a crystalline form of lorlatinib free base hydrate. This invention relates to a specific crystalline form of lorlatinib, which is used in pharmaceutical compositions aimed at treating abnormal cell growth in mammals. Another significant patent involves a process for preparing aryl piperazinyl-heterocyclic compounds. This process outlines a method for synthesizing compounds that can be used in various pharmaceutical applications.
Career Highlights
Paul Bowles is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with some of the brightest minds in the industry, contributing to advancements in drug development and therapeutic solutions.
Collaborations
Some of Bowles' notable coworkers include Frank R Busch and Douglas John. Their collaborative efforts have played a crucial role in the success of various projects within the pharmaceutical sector.
Conclusion
In summary, Paul Bowles is an accomplished inventor whose work in pharmaceutical chemistry has led to significant advancements in cancer treatment. His innovative patents and collaborations at Pfizer Corporation highlight his commitment to improving healthcare through scientific research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
